Abstract
Chikungunya virus (CHIKV) has been a worldwide threat since its reemergence in La Reunion Island in 2004. Expression of the interferon-stimulated protein Viperin correlates with viral load burden in patients, and studies in mice have demonstrated its role to limit disease severity against CHIKV infection. Using Viperin2/2 mice, we aimed to understand the contribution of Viperin to the T-cell immune response against CHIKV. CD4 T-cell depletion in Viperin2/2 mice showed that increased late acute joint inflammation (5-8 d postinfection) was exclusively mediated by T cells. Specifically, CHIKV-infected Viperin2/2 mice showed an increased INFγ Th1 profile of CD4 T cells, enhanced INFγ stimulation by APCs, an increased INFγ secretion profile in the joint microenvironment, and increased numbers of inflammatory monocytes in virus-infected joints compared with WT mice. Bone marrow grafting experiments showed that Viperin expression in both hematopoietic and non-hematopoietic cells is instrumental in reducing disease severity associated with a CD4 T-cell response.
Cite
CITATION STYLE
Carissimo, G., Teo, T. H., Chan, Y. H., Lee, C. Y. P., Lee, B., Torres-Ruesta, A., … Ng, L. F. P. (2019). Viperin controls chikungunya virus-specific pathogenic T cell IFNγ Th1 stimulation in mice. Life Science Alliance, 2(1). https://doi.org/10.26508/lsa.201900298
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.